In order to provide complete functionality, this web site needs your explicit consent to store browser cookies. If you don't allow cookies, you may not be able to use certain features of the web site including but not limited to: log in, buy products, see personalized content, switch between site cultures. It is recommended that you allow all cookies.
Learn more about our policy
EN
FR
Search for:
Navigation
Services
Preclinical solutions
Clinical trials
Biomarkers solution
ELISA Kits
Home
About us
The company
The executive team
Facilities
References
Certifications
Jobs
News & Events
News & Publications
Events
Testimonials
FAQ
Contact
News & Events
>
News & Publications
>
Artialis launchs its Sarcopenia Research Program!
Published on 14/12/2018
Artialis launchs its Sarcopenia Research Program!
In September 2018, Artialis has started its 4 million euros Sarcopenia Research Program. This project named "DEMAIN", partially granted by the Public Service of Wallonia, proposes an integrated approach for the development of sarcopenia biomarkers.
Artialis is currently working on the investigators recruitment. The patients enrolment to this trial will start in early January.
Read the press release
Our latest news
20/08/2019
Coll2-1, a biomarker of cartilage degradation, is involved in osteoarthritis physiopathology
16/07/2019
Coll-2-1 demonstrates the efficacy of an hyaluronic acid treatment (HYMOVIS®)
Read more
News & Publications
Events
Testimonials
© Artialis - All rights reserved
Terms & conditions
-
Privacy Policy
Made by